π Our Expansion Journey
We are proud to announce a major step forward in our manufacturing capabilities, reinforcing our commitment to quality, compliance, and innovation.
π May 2026 β Strategic Planning
Exploring lease or purchase options for a dedicated manufacturing facility.
ποΈ June 2026 β cGMP Facility Setup
A 2,150 sq. ft. cGMP-compliant facility within a 10,000 sq. ft. industrial manufacturing setup including:
- Sampling booths
- In-process testing laboratory
- Dispensing booths
- Solid dosage form or Tablet manufacturing
- Mixing and sieving
- Dry granulation, moist heat granulation, and drying
- Tablet Compression, and Coating
- Finish product testing laboratory
- Stability study area
β JulyβAugust 2026 β Inspection & Approval
FDA or third-party inspection for cGMP compliance and approval.